AIDS Treatment Update, Issue 63, March 1998
Edward King
- people who are currently stable on hard gel saquinavir - people who are failing on another protease inhibitor - people who have never taken a protease inhibitor before
However, if you are failing on saquinavir at the moment, Roche does not recommend switching to the soft gel formulation since this is unlikely to overcome drug-resistant virus more effectively.
People taking the hard gel formulation of saquinavir in combination with ritonavir do not need to switch, because studies suggest that there is no difference in blood levels of saquinavir when either of the two formulations is used in combination with ritonavir.
For more details, doctors should call Ben Wills on 01707 365707.
980305
ATU6306
Copyright © 1998 - AIDS Treatment Update. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. NAM Publications 16a Clapham Common Southside, London, England SW4 7AB; TEL: 01-71-627-3200 (from outside the UK: +44-171-627-3200); FAX: 01-71-627-3101 (from outside the UK: +44=171-627-3101) info@nam.org.uk http://www.nam.org.uk